WittKieffer’s proprietary analysis provides a comprehensive, data-driven exploration of CFO transitions and phenotypes within PE-backed healthcare services companies. Our research reveals that 84% of companies replace their CFO post-acquisition, with transitions occurring on average 11 months after the deal.
Critical insights revealed:
Understanding CFO transition patterns, replacement timing, and phenotypes is critical for PE firms looking to optimize leadership within their healthcare portfolio companies. The distinction between operational and strategic finance leaders provides a framework for matching CFO capabilities to specific company needs and value creation objectives. This research offers investors and healthcare leaders insights and actionable recommendations for more effective talent selection, onboarding, and succession planning in an increasingly complex healthcare investment landscape.

Shelly Carolan, Managing Partner, Investor-backed Healthcare, has broad and deep expertise across the healthcare and life sciences industries and in particular in for-profit healthcare. Prior to her career in executive recruitment, she held a number of C-suite positions at PE-backed and private healthcare service organizations. As leader of WittKieffer's Investor-Backed Healthcare Practice, she conducts and oversees high-level searches and manages quality, and consistency of the teams work for for-profit healthcare clients.